KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Notes Payables (2020 - 2024)

Labcorp Holdings' Notes Payables history spans 8 years, with the latest figure at $1.4 billion for Q3 2024.

  • For Q3 2024, Notes Payables rose 41.26% year-over-year to $1.4 billion; the TTM value through Sep 2024 reached $1.4 billion, up 41.26%, while the annual FY2023 figure was $999.8 million, 231.83% up from the prior year.
  • Notes Payables for Q3 2024 was $1.4 billion at Labcorp Holdings, down from $2.0 billion in the prior quarter.
  • Across five years, Notes Payables topped out at $2.0 billion in Q1 2024 and bottomed at $1.5 million in Q4 2021.
  • The 5-year median for Notes Payables is $301.4 million (2023), against an average of $577.7 million.
  • The largest annual shift saw Notes Payables crashed 99.68% in 2022 before it soared 58194.12% in 2023.
  • A 5-year view of Notes Payables shows it stood at $376.7 million in 2020, then crashed by 99.6% to $1.5 million in 2021, then soared by 19986.67% to $301.3 million in 2022, then surged by 231.83% to $999.8 million in 2023, then soared by 40.02% to $1.4 billion in 2024.
  • Per Business Quant, the three most recent readings for LH's Notes Payables are $1.4 billion (Q3 2024), $2.0 billion (Q2 2024), and $2.0 billion (Q1 2024).